|
| Drug rejection shows FDA staying cautious |
7 May 08, 10:19 |
|
| The rejection last week of a new and highly anticipated cholesterol drug from Merck took the company and Wall Street by surprise. But several leading heart researchers say the setback was part of a growing reluctance by the Food and Drug Administration to approve new drugs. |
| more |
|
